Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
3601
3602
3603
3604
3605
3606
3607
3608
3609
3610
3611
3612
3613
3614
3615
3616
3617
3618
3619
3620
3621
3622
3623
3624
3625
3626
3627
3628
3629
3630
3631
3632
3633
3634
3635
3636
3637
3638
3639
3640
3641
3642
3643
3644
3645
3646
3647
3648
3649
3650
3651
3652
3653
3654
3655
3656
3657
3658
3659
3660
3661
3662
3663
3664
3665
3666
3667
3668
3669
3670
3671
3672
3673
3674
3675
3676
3677
3678
3679
3680
3681
3682
3683
3684
3685
3686
3687
3688
3689
3690
3691
3692
3693
3694
3695
3696
3697
3698
3699
3700
3701
3702
3703
3704
3705
3706
3707
3708
3709
3710
3711
3712
3713
3714
3715
3716
3717
3718
3719
3720
3721
3722
3723
3724
3725
3726
3727
3728
3729
3730
3731
3732
3733
3734
3735
3736
3737
3738
3739
3740
3741
3742
3743
3744
3745
3746
3747
3748
3749
3750
3751
3752
3753
3754
3755
3756
3757
3758
3759
3760
3761
3762
3763
3764
3765
3766
3767
3768
3769
3770
3771
3772
3773
3774
3775
3776
3777
3778
3779
3780
3781
3782
3783
3784
3785
3786
3787
3788
3789
3790
3791
3792
3793
3794
3795
3796
3797
3798
3799
3800
| UnnamedSample_HQ_transcript/55826|m.15197 | UnnamedSample_HQ_transcript/55826 | Coverage 0.900 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 1.5E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/92734|m.21624 | UnnamedSample_HQ_transcript/92734 | Coverage 0.852 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 16 | 84 | 3.0E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/92734|m.21624 | UnnamedSample_HQ_transcript/92734 | Coverage 0.852 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 1.5E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/15725|m.5622 | UnnamedSample_HQ_transcript/15725 | Coverage 0.946 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 16 | 84 | 3.0E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/15725|m.5622 | UnnamedSample_HQ_transcript/15725 | Coverage 0.946 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 1.5E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/74562|m.18748 | UnnamedSample_HQ_transcript/74562 | Coverage 0.965 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 16 | 84 | 3.0E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/74562|m.18748 | UnnamedSample_HQ_transcript/74562 | Coverage 0.965 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 1.5E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/63365|m.16705 | UnnamedSample_HQ_transcript/63365 | Coverage 0.886 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 16 | 84 | 3.0E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/63365|m.16705 | UnnamedSample_HQ_transcript/63365 | Coverage 0.886 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 1.5E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/60961|m.16253 | UnnamedSample_HQ_transcript/60961 | Coverage 0.893 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 16 | 84 | 3.0E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/60961|m.16253 | UnnamedSample_HQ_transcript/60961 | Coverage 0.893 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 1.5E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/76082|m.19039 | UnnamedSample_HQ_transcript/76082 | Coverage 0.954 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 16 | 84 | 3.0E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/76082|m.19039 | UnnamedSample_HQ_transcript/76082 | Coverage 0.954 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 1.5E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/12228|m.4568 | UnnamedSample_HQ_transcript/12228 | Coverage 0.050 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 16 | 84 | 3.0E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/12228|m.4568 | UnnamedSample_HQ_transcript/12228 | Coverage 0.050 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 1.5E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/68357|m.17647 | UnnamedSample_HQ_transcript/68357 | Coverage 0.904 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 16 | 84 | 3.0E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/68357|m.17647 | UnnamedSample_HQ_transcript/68357 | Coverage 0.904 too low. | 0af9c28163a69c56da57f6d30707b082 | 353 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 1.5E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/44910|m.12892 | UnnamedSample_HQ_transcript/44910 | Coverage 0.981 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF02020 | eIF4-gamma/eIF5/eIF2-epsilon | 312 | 394 | 5.4E-22 | T | 22-09-2020 | IPR003307 | W2 domain |
| UnnamedSample_HQ_transcript/44910|m.12892 | UnnamedSample_HQ_transcript/44910 | Coverage 0.981 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF01873 | Domain found in IF2B/IF5 | 8 | 128 | 2.4E-39 | T | 22-09-2020 | IPR002735 | Translation initiation factor IF2/IF5 |
| UnnamedSample_HQ_transcript/55888|m.15212 | UnnamedSample_HQ_transcript/55888 | Coverage 0.989 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF02020 | eIF4-gamma/eIF5/eIF2-epsilon | 312 | 394 | 5.4E-22 | T | 22-09-2020 | IPR003307 | W2 domain |
| UnnamedSample_HQ_transcript/55888|m.15212 | UnnamedSample_HQ_transcript/55888 | Coverage 0.989 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF01873 | Domain found in IF2B/IF5 | 8 | 128 | 2.4E-39 | T | 22-09-2020 | IPR002735 | Translation initiation factor IF2/IF5 |
| UnnamedSample_HQ_transcript/48584|m.13715 | UnnamedSample_HQ_transcript/48584 | Identity 0.942 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF02020 | eIF4-gamma/eIF5/eIF2-epsilon | 312 | 394 | 5.4E-22 | T | 22-09-2020 | IPR003307 | W2 domain |
| UnnamedSample_HQ_transcript/48584|m.13715 | UnnamedSample_HQ_transcript/48584 | Identity 0.942 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF01873 | Domain found in IF2B/IF5 | 8 | 128 | 2.4E-39 | T | 22-09-2020 | IPR002735 | Translation initiation factor IF2/IF5 |
| UnnamedSample_HQ_transcript/49993|m.14023 | UnnamedSample_HQ_transcript/49993 | Identity 0.945 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF02020 | eIF4-gamma/eIF5/eIF2-epsilon | 312 | 394 | 5.4E-22 | T | 22-09-2020 | IPR003307 | W2 domain |
| UnnamedSample_HQ_transcript/49993|m.14023 | UnnamedSample_HQ_transcript/49993 | Identity 0.945 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF01873 | Domain found in IF2B/IF5 | 8 | 128 | 2.4E-39 | T | 22-09-2020 | IPR002735 | Translation initiation factor IF2/IF5 |
| UnnamedSample_HQ_transcript/55352|m.15101 | UnnamedSample_HQ_transcript/55352 | Coverage 0.973 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF02020 | eIF4-gamma/eIF5/eIF2-epsilon | 312 | 394 | 5.4E-22 | T | 22-09-2020 | IPR003307 | W2 domain |
| UnnamedSample_HQ_transcript/55352|m.15101 | UnnamedSample_HQ_transcript/55352 | Coverage 0.973 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF01873 | Domain found in IF2B/IF5 | 8 | 128 | 2.4E-39 | T | 22-09-2020 | IPR002735 | Translation initiation factor IF2/IF5 |
| UnnamedSample_HQ_transcript/47452|m.13455 | UnnamedSample_HQ_transcript/47452 | Coverage 0.972 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF02020 | eIF4-gamma/eIF5/eIF2-epsilon | 312 | 394 | 5.4E-22 | T | 22-09-2020 | IPR003307 | W2 domain |
| UnnamedSample_HQ_transcript/47452|m.13455 | UnnamedSample_HQ_transcript/47452 | Coverage 0.972 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF01873 | Domain found in IF2B/IF5 | 8 | 128 | 2.4E-39 | T | 22-09-2020 | IPR002735 | Translation initiation factor IF2/IF5 |
| UnnamedSample_HQ_transcript/67218|m.17445 | UnnamedSample_HQ_transcript/67218 | Identity 0.936 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF02020 | eIF4-gamma/eIF5/eIF2-epsilon | 312 | 394 | 5.4E-22 | T | 22-09-2020 | IPR003307 | W2 domain |
| UnnamedSample_HQ_transcript/67218|m.17445 | UnnamedSample_HQ_transcript/67218 | Identity 0.936 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF01873 | Domain found in IF2B/IF5 | 8 | 128 | 2.4E-39 | T | 22-09-2020 | IPR002735 | Translation initiation factor IF2/IF5 |
| UnnamedSample_HQ_transcript/56924|m.15426 | UnnamedSample_HQ_transcript/56924 | Identity 0.948 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF02020 | eIF4-gamma/eIF5/eIF2-epsilon | 312 | 394 | 5.4E-22 | T | 22-09-2020 | IPR003307 | W2 domain |
| UnnamedSample_HQ_transcript/56924|m.15426 | UnnamedSample_HQ_transcript/56924 | Identity 0.948 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF01873 | Domain found in IF2B/IF5 | 8 | 128 | 2.4E-39 | T | 22-09-2020 | IPR002735 | Translation initiation factor IF2/IF5 |
| UnnamedSample_HQ_transcript/46471|m.13252 | UnnamedSample_HQ_transcript/46471 | Identity 0.948 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF02020 | eIF4-gamma/eIF5/eIF2-epsilon | 312 | 394 | 5.4E-22 | T | 22-09-2020 | IPR003307 | W2 domain |
| UnnamedSample_HQ_transcript/46471|m.13252 | UnnamedSample_HQ_transcript/46471 | Identity 0.948 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF01873 | Domain found in IF2B/IF5 | 8 | 128 | 2.4E-39 | T | 22-09-2020 | IPR002735 | Translation initiation factor IF2/IF5 |
| UnnamedSample_HQ_transcript/47015|m.13367 | UnnamedSample_HQ_transcript/47015 | Identity 0.947 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF02020 | eIF4-gamma/eIF5/eIF2-epsilon | 312 | 394 | 5.4E-22 | T | 22-09-2020 | IPR003307 | W2 domain |
| UnnamedSample_HQ_transcript/47015|m.13367 | UnnamedSample_HQ_transcript/47015 | Identity 0.947 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF01873 | Domain found in IF2B/IF5 | 8 | 128 | 2.4E-39 | T | 22-09-2020 | IPR002735 | Translation initiation factor IF2/IF5 |
| UnnamedSample_HQ_transcript/43424|m.12585 | UnnamedSample_HQ_transcript/43424 | Identity 0.947 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF02020 | eIF4-gamma/eIF5/eIF2-epsilon | 312 | 394 | 5.4E-22 | T | 22-09-2020 | IPR003307 | W2 domain |
| UnnamedSample_HQ_transcript/43424|m.12585 | UnnamedSample_HQ_transcript/43424 | Identity 0.947 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF01873 | Domain found in IF2B/IF5 | 8 | 128 | 2.4E-39 | T | 22-09-2020 | IPR002735 | Translation initiation factor IF2/IF5 |
| UnnamedSample_HQ_transcript/64074|m.16857 | UnnamedSample_HQ_transcript/64074 | Identity 0.932 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF02020 | eIF4-gamma/eIF5/eIF2-epsilon | 312 | 394 | 5.4E-22 | T | 22-09-2020 | IPR003307 | W2 domain |
| UnnamedSample_HQ_transcript/64074|m.16857 | UnnamedSample_HQ_transcript/64074 | Identity 0.932 too low. | 330552f6ffa9ea2abd3278bb91211f13 | 440 | Pfam | PF01873 | Domain found in IF2B/IF5 | 8 | 128 | 2.4E-39 | T | 22-09-2020 | IPR002735 | Translation initiation factor IF2/IF5 |
| UnnamedSample_HQ_transcript/43563|m.12610 | UnnamedSample_HQ_transcript/43563 | Coverage 0.389 too low. | 8890c5439ac42f0e4a724de0beb00305 | 402 | Pfam | PF01699 | Sodium/calcium exchanger protein | 233 | 382 | 1.8E-29 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/43563|m.12610 | UnnamedSample_HQ_transcript/43563 | Coverage 0.389 too low. | 8890c5439ac42f0e4a724de0beb00305 | 402 | Pfam | PF01699 | Sodium/calcium exchanger protein | 1 | 101 | 8.5E-13 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/56060|m.15249 | UnnamedSample_HQ_transcript/56060 | Identity 0.640 too low. | 631c28058ef91708a0ac1350ff5871a3 | 488 | Pfam | PF13927 | Immunoglobulin domain | 185 | 264 | 4.1E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/56060|m.15249 | UnnamedSample_HQ_transcript/56060 | Identity 0.640 too low. | 631c28058ef91708a0ac1350ff5871a3 | 488 | Pfam | PF00041 | Fibronectin type III domain | 398 | 459 | 5.1E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/5830|m.2472 | UnnamedSample_HQ_transcript/5830 | Coverage 0.325 too low. | a455e681703cdbc14c6a532a4a3cc24c | 575 | Pfam | PF00012 | Hsp70 protein | 1 | 541 | 4.5E-173 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/104308|m.23147 | UnnamedSample_HQ_transcript/104308 | Coverage 0.987 too low. | b08d86d1057756bb26783f237336647b | 130 | Pfam | PF04721 | PNGase C-terminal domain, mannose-binding module PAW | 1 | 124 | 4.6E-38 | T | 22-09-2020 | IPR006588 | Peptide N glycanase, PAW domain |
| UnnamedSample_HQ_transcript/57159|m.15479 | UnnamedSample_HQ_transcript/57159 | Coverage 0.964 too low. | 878739fd5d8c012ce975a702acac99e4 | 578 | Pfam | PF00651 | BTB/POZ domain | 400 | 505 | 2.0E-18 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/61425|m.16343 | UnnamedSample_HQ_transcript/61425 | Coverage 0.973 too low. | 878739fd5d8c012ce975a702acac99e4 | 578 | Pfam | PF00651 | BTB/POZ domain | 400 | 505 | 2.0E-18 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/36744|m.11101 | UnnamedSample_HQ_transcript/36744 | Identity 0.938 too low. | c9e7ef462d947214f1724cf3a4933e68 | 610 | Pfam | PF06325 | Ribosomal protein L11 methyltransferase (PrmA) | 130 | 203 | 3.7E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 957 | 1067 | 2.2E-43 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 849 | 952 | 2.3E-37 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 391 | 446 | 1.8E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 294 | 350 | 9.3E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 230 | 285 | 2.8E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 145 | 201 | 6.8E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 778 | 836 | 9.5E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 332 | 389 | 4.4E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 456 | 510 | 1.6E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 200 | 258 | 1.1E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 732 | 788 | 3.7E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 81 | 139 | 4.3E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 691 | 748 | 2.1E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/12758|m.4744 | UnnamedSample_HQ_transcript/12758 | Coverage 0.784 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 47 | 99 | 4.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 957 | 1067 | 2.2E-43 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 849 | 952 | 2.3E-37 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 391 | 446 | 1.8E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 294 | 350 | 9.3E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 230 | 285 | 2.8E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 145 | 201 | 6.8E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 778 | 836 | 9.5E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 332 | 389 | 4.4E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 456 | 510 | 1.6E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 200 | 258 | 1.1E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 732 | 788 | 3.7E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 81 | 139 | 4.3E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 691 | 748 | 2.1E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/13941|m.5095 | UnnamedSample_HQ_transcript/13941 | Coverage 0.833 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 47 | 99 | 4.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 957 | 1067 | 2.2E-43 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 849 | 952 | 2.3E-37 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 391 | 446 | 1.8E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 294 | 350 | 9.3E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 230 | 285 | 2.8E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 145 | 201 | 6.8E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 778 | 836 | 9.5E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 332 | 389 | 4.4E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 456 | 510 | 1.6E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 200 | 258 | 1.1E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 732 | 788 | 3.7E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 81 | 139 | 4.3E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 691 | 748 | 2.1E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/8482|m.3345 | UnnamedSample_HQ_transcript/8482 | Coverage 0.713 too low. | 129a814d7ee81a2f91f66f84e8ef8410 | 1069 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 47 | 99 | 4.6E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/21695|m.7341 | UnnamedSample_HQ_transcript/21695 | Coverage 0.977 too low. | 80be67e24a69a6f15b203bf872d9491c | 1064 | Pfam | PF00176 | SNF2 family N-terminal domain | 544 | 832 | 9.4E-73 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/21695|m.7341 | UnnamedSample_HQ_transcript/21695 | Coverage 0.977 too low. | 80be67e24a69a6f15b203bf872d9491c | 1064 | Pfam | PF07533 | BRK domain | 417 | 457 | 7.2E-14 | T | 22-09-2020 | IPR006576 | BRK domain |
| UnnamedSample_HQ_transcript/21695|m.7341 | UnnamedSample_HQ_transcript/21695 | Coverage 0.977 too low. | 80be67e24a69a6f15b203bf872d9491c | 1064 | Pfam | PF07529 | HSA | 274 | 344 | 1.2E-17 | T | 22-09-2020 | IPR014012 | Helicase/SANT-associated domain |
| UnnamedSample_HQ_transcript/21695|m.7341 | UnnamedSample_HQ_transcript/21695 | Coverage 0.977 too low. | 80be67e24a69a6f15b203bf872d9491c | 1064 | Pfam | PF00271 | Helicase conserved C-terminal domain | 861 | 974 | 1.2E-19 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/21695|m.7341 | UnnamedSample_HQ_transcript/21695 | Coverage 0.977 too low. | 80be67e24a69a6f15b203bf872d9491c | 1064 | Pfam | PF08880 | QLQ | 22 | 56 | 8.4E-10 | T | 22-09-2020 | IPR014978 | Glutamine-Leucine-Glutamine, QLQ |
| UnnamedSample_HQ_transcript/36248|m.10989 | UnnamedSample_HQ_transcript/36248 | Coverage 0.840 too low. | 0bbedb9d345816c4025dbac94a62c446 | 548 | Pfam | PF02822 | Antistasin family | 345 | 371 | 1.2E-7 | T | 22-09-2020 | IPR004094 | Antistasin-like domain |
| UnnamedSample_HQ_transcript/36248|m.10989 | UnnamedSample_HQ_transcript/36248 | Coverage 0.840 too low. | 0bbedb9d345816c4025dbac94a62c446 | 548 | Pfam | PF00093 | von Willebrand factor type C domain | 493 | 546 | 8.0E-9 | T | 22-09-2020 | IPR001007 | VWFC domain |
| UnnamedSample_HQ_transcript/73171|m.18503 | UnnamedSample_HQ_transcript/73171 | Identity 0.929 too low. | 3a40f5c1a30522155c9f5dfb2f8b2fb5 | 169 | Pfam | PF00135 | Carboxylesterase family | 1 | 169 | 2.6E-20 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/110970|m.23962 | UnnamedSample_HQ_transcript/110970 | Coverage 0.971 too low. | f75ee95548f98529387d8e790385277f | 174 | Pfam | PF00467 | KOW motif | 10 | 38 | 2.9E-5 | T | 22-09-2020 | IPR005824 | KOW |
| UnnamedSample_HQ_transcript/110970|m.23962 | UnnamedSample_HQ_transcript/110970 | Coverage 0.971 too low. | f75ee95548f98529387d8e790385277f | 174 | Pfam | PF01929 | Ribosomal protein L14 | 46 | 120 | 1.6E-25 | T | 22-09-2020 | IPR002784 | Ribosomal protein L14e domain |
| UnnamedSample_HQ_transcript/115201|m.24416 | UnnamedSample_HQ_transcript/115201 | Coverage 0.952 too low. | 5ccac74b8a055bc19edd3daff56aee6a | 204 | Pfam | PF08669 | Glycine cleavage T-protein C-terminal barrel domain | 115 | 192 | 6.0E-17 | T | 22-09-2020 | IPR013977 | Glycine cleavage T-protein, C-terminal barrel domain |
| UnnamedSample_HQ_transcript/115201|m.24416 | UnnamedSample_HQ_transcript/115201 | Coverage 0.952 too low. | 5ccac74b8a055bc19edd3daff56aee6a | 204 | Pfam | PF01571 | Aminomethyltransferase folate-binding domain | 9 | 87 | 6.6E-30 | T | 22-09-2020 | IPR006222 | Aminomethyltransferase, folate-binding domain |
| UnnamedSample_HQ_transcript/17343|m.6107 | UnnamedSample_HQ_transcript/17343 | Coverage 0.915 too low. | 7559877a5829dc5c8a4d193046241fd5 | 179 | Pfam | PF00487 | Fatty acid desaturase | 5 | 168 | 1.1E-11 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/2580|m.1266 | UnnamedSample_HQ_transcript/2580 | Coverage 0.932 too low. | 0044d85a7383280edcabd517d7bce44f | 1376 | Pfam | PF13927 | Immunoglobulin domain | 431 | 503 | 1.2E-15 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/2580|m.1266 | UnnamedSample_HQ_transcript/2580 | Coverage 0.932 too low. | 0044d85a7383280edcabd517d7bce44f | 1376 | Pfam | PF13927 | Immunoglobulin domain | 56 | 116 | 1.9E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/2580|m.1266 | UnnamedSample_HQ_transcript/2580 | Coverage 0.932 too low. | 0044d85a7383280edcabd517d7bce44f | 1376 | Pfam | PF13927 | Immunoglobulin domain | 250 | 320 | 4.2E-13 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/2580|m.1266 | UnnamedSample_HQ_transcript/2580 | Coverage 0.932 too low. | 0044d85a7383280edcabd517d7bce44f | 1376 | Pfam | PF00041 | Fibronectin type III domain | 1133 | 1213 | 3.4E-7 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/2580|m.1266 | UnnamedSample_HQ_transcript/2580 | Coverage 0.932 too low. | 0044d85a7383280edcabd517d7bce44f | 1376 | Pfam | PF00041 | Fibronectin type III domain | 623 | 699 | 4.0E-7 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/2580|m.1266 | UnnamedSample_HQ_transcript/2580 | Coverage 0.932 too low. | 0044d85a7383280edcabd517d7bce44f | 1376 | Pfam | PF00041 | Fibronectin type III domain | 820 | 903 | 1.6E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/2580|m.1266 | UnnamedSample_HQ_transcript/2580 | Coverage 0.932 too low. | 0044d85a7383280edcabd517d7bce44f | 1376 | Pfam | PF00041 | Fibronectin type III domain | 1234 | 1322 | 2.6E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/2580|m.1266 | UnnamedSample_HQ_transcript/2580 | Coverage 0.932 too low. | 0044d85a7383280edcabd517d7bce44f | 1376 | Pfam | PF00041 | Fibronectin type III domain | 1030 | 1112 | 3.0E-7 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/2580|m.1266 | UnnamedSample_HQ_transcript/2580 | Coverage 0.932 too low. | 0044d85a7383280edcabd517d7bce44f | 1376 | Pfam | PF07679 | Immunoglobulin I-set domain | 338 | 426 | 1.2E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/2580|m.1266 | UnnamedSample_HQ_transcript/2580 | Coverage 0.932 too low. | 0044d85a7383280edcabd517d7bce44f | 1376 | Pfam | PF07679 | Immunoglobulin I-set domain | 531 | 610 | 6.2E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/64479|m.16943 | UnnamedSample_HQ_transcript/64479 | Coverage 0.870 too low. | c87562d69ca5893ce30d6e5d8856440e | 433 | Pfam | PF02931 | Neurotransmitter-gated ion-channel ligand binding domain | 25 | 204 | 3.2E-27 | T | 22-09-2020 | IPR006202 | Neurotransmitter-gated ion-channel ligand-binding domain |
| UnnamedSample_HQ_transcript/64479|m.16943 | UnnamedSample_HQ_transcript/64479 | Coverage 0.870 too low. | c87562d69ca5893ce30d6e5d8856440e | 433 | Pfam | PF02932 | Neurotransmitter-gated ion-channel transmembrane region | 235 | 327 | 6.0E-11 | T | 22-09-2020 | IPR006029 | Neurotransmitter-gated ion-channel transmembrane domain |
| UnnamedSample_HQ_transcript/104189|m.23133 | UnnamedSample_HQ_transcript/104189 | Coverage 0.971 too low. | d7b84815548bcd20411efaf865ec8844 | 280 | Pfam | PF03723 | Hemocyanin, ig-like domain | 11 | 265 | 2.4E-79 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/106080|m.23342 | UnnamedSample_HQ_transcript/106080 | Coverage 0.970 too low. | d7b84815548bcd20411efaf865ec8844 | 280 | Pfam | PF03723 | Hemocyanin, ig-like domain | 11 | 265 | 2.4E-79 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/46430|m.13239 | UnnamedSample_HQ_transcript/46430 | Identity 0.907 too low. | 3d06b36f4d8ddaec02397778a527fdf7 | 240 | Pfam | PF06031 | SERTA motif | 98 | 132 | 1.3E-15 | T | 22-09-2020 | IPR009263 | SERTA domain |
| UnnamedSample_HQ_transcript/96183|m.22117 | UnnamedSample_HQ_transcript/96183 | Coverage 0.908 too low. | 250883f868d7b2487889f9363c87fc01 | 193 | Pfam | PF07002 | Copine | 2 | 187 | 4.5E-72 | T | 22-09-2020 | IPR010734 | Copine |
| UnnamedSample_HQ_transcript/23938|m.7930 | UnnamedSample_HQ_transcript/23938 | Coverage 0.963 too low. | eccb6931074189918cd94912b20513a2 | 737 | Pfam | PF04389 | Peptidase family M28 | 10 | 202 | 1.8E-43 | T | 22-09-2020 | IPR007484 | Peptidase M28 |
| UnnamedSample_HQ_transcript/25205|m.8267 | UnnamedSample_HQ_transcript/25205 | Coverage 0.134 too low. | fdf81c9ce6eb728ead4a84358459ad86 | 998 | Pfam | PF06367 | Diaphanous FH3 Domain | 57 | 238 | 2.2E-28 | T | 22-09-2020 | IPR010472 | Formin, FH3 domain |
| UnnamedSample_HQ_transcript/25205|m.8267 | UnnamedSample_HQ_transcript/25205 | Coverage 0.134 too low. | fdf81c9ce6eb728ead4a84358459ad86 | 998 | Pfam | PF02181 | Formin Homology 2 Domain | 356 | 739 | 4.2E-86 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/2349|m.1190 | UnnamedSample_HQ_transcript/2349 | Identity 0.861 too low. | 6281552a1433658240dc5dc9357d2044 | 487 | Pfam | PF01237 | Oxysterol-binding protein | 120 | 463 | 6.8E-80 | T | 22-09-2020 | IPR000648 | Oxysterol-binding protein |
| UnnamedSample_HQ_transcript/31944|m.9935 | UnnamedSample_HQ_transcript/31944 | Coverage 0.047 too low. | bef9edebf1439fbe66d0bd1e363764f6 | 907 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 262 | 315 | 5.1E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/31944|m.9935 | UnnamedSample_HQ_transcript/31944 | Coverage 0.047 too low. | bef9edebf1439fbe66d0bd1e363764f6 | 907 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 184 | 244 | 5.3E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/31944|m.9935 | UnnamedSample_HQ_transcript/31944 | Coverage 0.047 too low. | bef9edebf1439fbe66d0bd1e363764f6 | 907 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 68 | 125 | 3.2E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/31944|m.9935 | UnnamedSample_HQ_transcript/31944 | Coverage 0.047 too low. | bef9edebf1439fbe66d0bd1e363764f6 | 907 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 310 | 365 | 1.7E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/31944|m.9935 | UnnamedSample_HQ_transcript/31944 | Coverage 0.047 too low. | bef9edebf1439fbe66d0bd1e363764f6 | 907 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 562 | 616 | 3.9E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/31944|m.9935 | UnnamedSample_HQ_transcript/31944 | Coverage 0.047 too low. | bef9edebf1439fbe66d0bd1e363764f6 | 907 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 376 | 426 | 2.1E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/31944|m.9935 | UnnamedSample_HQ_transcript/31944 | Coverage 0.047 too low. | bef9edebf1439fbe66d0bd1e363764f6 | 907 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 632 | 685 | 6.3E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/41527|m.12164 | UnnamedSample_HQ_transcript/41527 | Coverage 0.834 too low. | 43ad0208c699ab40fd9c365d466842a5 | 619 | Pfam | PF02135 | TAZ zinc finger | 30 | 101 | 8.0E-12 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/41527|m.12164 | UnnamedSample_HQ_transcript/41527 | Coverage 0.834 too low. | 43ad0208c699ab40fd9c365d466842a5 | 619 | Pfam | PF09030 | Creb binding | 338 | 419 | 1.1E-16 | T | 22-09-2020 | IPR014744 | Nuclear receptor coactivator, CREB-bp-like, interlocking |
| UnnamedSample_HQ_transcript/50889|m.14221 | UnnamedSample_HQ_transcript/50889 | Coverage 0.902 too low. | 43ad0208c699ab40fd9c365d466842a5 | 619 | Pfam | PF02135 | TAZ zinc finger | 30 | 101 | 8.0E-12 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/50889|m.14221 | UnnamedSample_HQ_transcript/50889 | Coverage 0.902 too low. | 43ad0208c699ab40fd9c365d466842a5 | 619 | Pfam | PF09030 | Creb binding | 338 | 419 | 1.1E-16 | T | 22-09-2020 | IPR014744 | Nuclear receptor coactivator, CREB-bp-like, interlocking |
| UnnamedSample_HQ_transcript/34936|m.10709 | UnnamedSample_HQ_transcript/34936 | Coverage 0.747 too low. | 43ad0208c699ab40fd9c365d466842a5 | 619 | Pfam | PF02135 | TAZ zinc finger | 30 | 101 | 8.0E-12 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/34936|m.10709 | UnnamedSample_HQ_transcript/34936 | Coverage 0.747 too low. | 43ad0208c699ab40fd9c365d466842a5 | 619 | Pfam | PF09030 | Creb binding | 338 | 419 | 1.1E-16 | T | 22-09-2020 | IPR014744 | Nuclear receptor coactivator, CREB-bp-like, interlocking |
| UnnamedSample_HQ_transcript/38888|m.11600 | UnnamedSample_HQ_transcript/38888 | Coverage 0.952 too low. | c1342043d517d46042389bfaa7bfd88a | 699 | Pfam | PF00271 | Helicase conserved C-terminal domain | 508 | 617 | 1.6E-31 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/38888|m.11600 | UnnamedSample_HQ_transcript/38888 | Coverage 0.952 too low. | c1342043d517d46042389bfaa7bfd88a | 699 | Pfam | PF00270 | DEAD/DEAH box helicase | 294 | 472 | 2.2E-49 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/27811|m.8920 | UnnamedSample_HQ_transcript/27811 | Coverage 0.732 too low. | 0683c42516875629a03531dd52ea0857 | 689 | Pfam | PF02770 | Acyl-CoA dehydrogenase, middle domain | 149 | 259 | 1.5E-13 | T | 22-09-2020 | IPR006091 | Acyl-CoA oxidase/dehydrogenase, central domain |
| UnnamedSample_HQ_transcript/27811|m.8920 | UnnamedSample_HQ_transcript/27811 | Coverage 0.732 too low. | 0683c42516875629a03531dd52ea0857 | 689 | Pfam | PF01756 | Acyl-CoA oxidase | 506 | 682 | 1.1E-44 | T | 22-09-2020 | IPR002655 | Acyl-CoA oxidase, C-terminal |
| UnnamedSample_HQ_transcript/38699|m.11553 | UnnamedSample_HQ_transcript/38699 | Coverage 0.855 too low. | 0683c42516875629a03531dd52ea0857 | 689 | Pfam | PF02770 | Acyl-CoA dehydrogenase, middle domain | 149 | 259 | 1.5E-13 | T | 22-09-2020 | IPR006091 | Acyl-CoA oxidase/dehydrogenase, central domain |
| UnnamedSample_HQ_transcript/38699|m.11553 | UnnamedSample_HQ_transcript/38699 | Coverage 0.855 too low. | 0683c42516875629a03531dd52ea0857 | 689 | Pfam | PF01756 | Acyl-CoA oxidase | 506 | 682 | 1.1E-44 | T | 22-09-2020 | IPR002655 | Acyl-CoA oxidase, C-terminal |
| UnnamedSample_HQ_transcript/30094|m.9497 | UnnamedSample_HQ_transcript/30094 | Coverage 0.753 too low. | 0683c42516875629a03531dd52ea0857 | 689 | Pfam | PF02770 | Acyl-CoA dehydrogenase, middle domain | 149 | 259 | 1.5E-13 | T | 22-09-2020 | IPR006091 | Acyl-CoA oxidase/dehydrogenase, central domain |
| UnnamedSample_HQ_transcript/30094|m.9497 | UnnamedSample_HQ_transcript/30094 | Coverage 0.753 too low. | 0683c42516875629a03531dd52ea0857 | 689 | Pfam | PF01756 | Acyl-CoA oxidase | 506 | 682 | 1.1E-44 | T | 22-09-2020 | IPR002655 | Acyl-CoA oxidase, C-terminal |
| UnnamedSample_HQ_transcript/30157|m.9516 | UnnamedSample_HQ_transcript/30157 | Coverage 0.753 too low. | 0683c42516875629a03531dd52ea0857 | 689 | Pfam | PF02770 | Acyl-CoA dehydrogenase, middle domain | 149 | 259 | 1.5E-13 | T | 22-09-2020 | IPR006091 | Acyl-CoA oxidase/dehydrogenase, central domain |
| UnnamedSample_HQ_transcript/30157|m.9516 | UnnamedSample_HQ_transcript/30157 | Coverage 0.753 too low. | 0683c42516875629a03531dd52ea0857 | 689 | Pfam | PF01756 | Acyl-CoA oxidase | 506 | 682 | 1.1E-44 | T | 22-09-2020 | IPR002655 | Acyl-CoA oxidase, C-terminal |
| UnnamedSample_HQ_transcript/30889|m.9677 | UnnamedSample_HQ_transcript/30889 | Coverage 0.765 too low. | 0683c42516875629a03531dd52ea0857 | 689 | Pfam | PF02770 | Acyl-CoA dehydrogenase, middle domain | 149 | 259 | 1.5E-13 | T | 22-09-2020 | IPR006091 | Acyl-CoA oxidase/dehydrogenase, central domain |
| UnnamedSample_HQ_transcript/30889|m.9677 | UnnamedSample_HQ_transcript/30889 | Coverage 0.765 too low. | 0683c42516875629a03531dd52ea0857 | 689 | Pfam | PF01756 | Acyl-CoA oxidase | 506 | 682 | 1.1E-44 | T | 22-09-2020 | IPR002655 | Acyl-CoA oxidase, C-terminal |
| UnnamedSample_HQ_transcript/36034|m.10942 | UnnamedSample_HQ_transcript/36034 | Coverage 0.838 too low. | 0683c42516875629a03531dd52ea0857 | 689 | Pfam | PF02770 | Acyl-CoA dehydrogenase, middle domain | 149 | 259 | 1.5E-13 | T | 22-09-2020 | IPR006091 | Acyl-CoA oxidase/dehydrogenase, central domain |
| UnnamedSample_HQ_transcript/36034|m.10942 | UnnamedSample_HQ_transcript/36034 | Coverage 0.838 too low. | 0683c42516875629a03531dd52ea0857 | 689 | Pfam | PF01756 | Acyl-CoA oxidase | 506 | 682 | 1.1E-44 | T | 22-09-2020 | IPR002655 | Acyl-CoA oxidase, C-terminal |
| UnnamedSample_HQ_transcript/29085|m.9251 | UnnamedSample_HQ_transcript/29085 | Coverage 0.454 too low. | 4b70ce3fde9e8d45c3a404fd6b9bf9ba | 466 | Pfam | PF00017 | SH2 domain | 82 | 159 | 1.7E-26 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/29085|m.9251 | UnnamedSample_HQ_transcript/29085 | Coverage 0.454 too low. | 4b70ce3fde9e8d45c3a404fd6b9bf9ba | 466 | Pfam | PF00018 | SH3 domain | 21 | 68 | 6.2E-18 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/29085|m.9251 | UnnamedSample_HQ_transcript/29085 | Coverage 0.454 too low. | 4b70ce3fde9e8d45c3a404fd6b9bf9ba | 466 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 200 | 448 | 4.2E-99 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/16092|m.5740 | UnnamedSample_HQ_transcript/16092 | Coverage 0.375 too low. | 4b70ce3fde9e8d45c3a404fd6b9bf9ba | 466 | Pfam | PF00017 | SH2 domain | 82 | 159 | 1.7E-26 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/16092|m.5740 | UnnamedSample_HQ_transcript/16092 | Coverage 0.375 too low. | 4b70ce3fde9e8d45c3a404fd6b9bf9ba | 466 | Pfam | PF00018 | SH3 domain | 21 | 68 | 6.2E-18 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/16092|m.5740 | UnnamedSample_HQ_transcript/16092 | Coverage 0.375 too low. | 4b70ce3fde9e8d45c3a404fd6b9bf9ba | 466 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 200 | 448 | 4.2E-99 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/57584|m.15562 | UnnamedSample_HQ_transcript/57584 | Identity 0.765 too low. | b4abe25c29650f1b47dbbca6deb2f5b7 | 258 | Pfam | PF00055 | Laminin N-terminal (Domain VI) | 41 | 253 | 1.2E-61 | T | 22-09-2020 | IPR008211 | Laminin, N-terminal |
| UnnamedSample_HQ_transcript/945|m.610 | UnnamedSample_HQ_transcript/945 | Coverage 0.149 too low. | 0e31251b97a03bccd8c01cae3f8c034a | 690 | Pfam | PF02210 | Laminin G domain | 327 | 446 | 1.2E-12 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/945|m.610 | UnnamedSample_HQ_transcript/945 | Coverage 0.149 too low. | 0e31251b97a03bccd8c01cae3f8c034a | 690 | Pfam | PF02210 | Laminin G domain | 146 | 267 | 1.1E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/945|m.610 | UnnamedSample_HQ_transcript/945 | Coverage 0.149 too low. | 0e31251b97a03bccd8c01cae3f8c034a | 690 | Pfam | PF02210 | Laminin G domain | 547 | 670 | 1.4E-22 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/78937|m.19538 | UnnamedSample_HQ_transcript/78937 | Coverage 0.938 too low. | 6e56031a5f01f138cb5a66134b769695 | 395 | Pfam | PF00441 | Acyl-CoA dehydrogenase, C-terminal domain | 68 | 214 | 7.3E-38 | T | 22-09-2020 | IPR009075 | Acyl-CoA dehydrogenase/oxidase C-terminal |
| UnnamedSample_HQ_transcript/543|m.403 | UnnamedSample_HQ_transcript/543 | Identity 0.929 too low. | 63cc1f267789da95d1fb8cdbb6d108a1 | 2028 | Pfam | PF00094 | von Willebrand factor type D domain | 1479 | 1617 | 1.1E-6 | T | 22-09-2020 | IPR001846 | von Willebrand factor, type D domain |
| UnnamedSample_HQ_transcript/11447|m.4309 | UnnamedSample_HQ_transcript/11447 | Coverage 0.206 too low. | 77ef22bcfdefd41cd7de2bd7c450a593 | 1073 | Pfam | PF02210 | Laminin G domain | 528 | 647 | 2.3E-12 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/11447|m.4309 | UnnamedSample_HQ_transcript/11447 | Coverage 0.206 too low. | 77ef22bcfdefd41cd7de2bd7c450a593 | 1073 | Pfam | PF02210 | Laminin G domain | 748 | 874 | 9.1E-23 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/11447|m.4309 | UnnamedSample_HQ_transcript/11447 | Coverage 0.206 too low. | 77ef22bcfdefd41cd7de2bd7c450a593 | 1073 | Pfam | PF02210 | Laminin G domain | 125 | 279 | 1.2E-16 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/11447|m.4309 | UnnamedSample_HQ_transcript/11447 | Coverage 0.206 too low. | 77ef22bcfdefd41cd7de2bd7c450a593 | 1073 | Pfam | PF02210 | Laminin G domain | 925 | 1052 | 3.8E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/11447|m.4309 | UnnamedSample_HQ_transcript/11447 | Coverage 0.206 too low. | 77ef22bcfdefd41cd7de2bd7c450a593 | 1073 | Pfam | PF02210 | Laminin G domain | 347 | 468 | 2.3E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/11447|m.4309 | UnnamedSample_HQ_transcript/11447 | Coverage 0.206 too low. | 77ef22bcfdefd41cd7de2bd7c450a593 | 1073 | Pfam | PF06009 | Laminin Domain II | 3 | 111 | 4.4E-8 | T | 22-09-2020 | IPR010307 | Laminin domain II |
| UnnamedSample_HQ_transcript/99998|m.22630 | UnnamedSample_HQ_transcript/99998 | Identity 0.944 too low. | 2d80ea6eaf7dd8690467f42097a7b1de | 361 | Pfam | PF01576 | Myosin tail | 15 | 361 | 2.1E-51 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/30213|m.9526 | UnnamedSample_HQ_transcript/30213 | Coverage 0.690 too low. | 8c259e0642764274be2c9e00b5bbd578 | 604 | Pfam | PF00178 | Ets-domain | 507 | 587 | 3.3E-34 | T | 22-09-2020 | IPR000418 | Ets domain |
| UnnamedSample_HQ_transcript/21592|m.7306 | UnnamedSample_HQ_transcript/21592 | Coverage 0.664 too low. | 8c259e0642764274be2c9e00b5bbd578 | 604 | Pfam | PF00178 | Ets-domain | 507 | 587 | 3.3E-34 | T | 22-09-2020 | IPR000418 | Ets domain |
| UnnamedSample_HQ_transcript/19964|m.6859 | UnnamedSample_HQ_transcript/19964 | Coverage 0.541 too low. | 14df58259f5ab1415f51f9b2f0a18782 | 388 | Pfam | PF18100 | Phosphodiesterase 4 upstream conserved regions (UCR) | 180 | 298 | 5.0E-54 | T | 22-09-2020 | IPR040844 | Phosphodiesterase 4 upstream conserved regions (UCR) |
| UnnamedSample_HQ_transcript/76245|m.19069 | UnnamedSample_HQ_transcript/76245 | Identity 0.621 too low. | ac9584f9de6d71a77463d1cea251f6e5 | 451 | Pfam | PF00501 | AMP-binding enzyme | 75 | 429 | 6.6E-56 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/90458|m.21321 | UnnamedSample_HQ_transcript/90458 | Identity 0.889 too low. | a6e27c24f6a0defe17b247a231eb3213 | 270 | Pfam | PF02779 | Transketolase, pyrimidine binding domain | 2 | 118 | 4.4E-31 | T | 22-09-2020 | IPR005475 | Transketolase-like, pyrimidine-binding domain |
| UnnamedSample_HQ_transcript/90458|m.21321 | UnnamedSample_HQ_transcript/90458 | Identity 0.889 too low. | a6e27c24f6a0defe17b247a231eb3213 | 270 | Pfam | PF02780 | Transketolase, C-terminal domain | 137 | 260 | 1.2E-38 | T | 22-09-2020 | IPR033248 | Transketolase, C-terminal domain |
| UnnamedSample_HQ_transcript/92765|m.21628 | UnnamedSample_HQ_transcript/92765 | Identity 0.889 too low. | a6e27c24f6a0defe17b247a231eb3213 | 270 | Pfam | PF02779 | Transketolase, pyrimidine binding domain | 2 | 118 | 4.4E-31 | T | 22-09-2020 | IPR005475 | Transketolase-like, pyrimidine-binding domain |
| UnnamedSample_HQ_transcript/92765|m.21628 | UnnamedSample_HQ_transcript/92765 | Identity 0.889 too low. | a6e27c24f6a0defe17b247a231eb3213 | 270 | Pfam | PF02780 | Transketolase, C-terminal domain | 137 | 260 | 1.2E-38 | T | 22-09-2020 | IPR033248 | Transketolase, C-terminal domain |
| UnnamedSample_HQ_transcript/28850|m.9182 | UnnamedSample_HQ_transcript/28850 | Unmapped. | ff74ebe559f8c1e02cb60de63b5914b5 | 933 | Pfam | PF08762 | CRPV capsid protein like | 635 | 845 | 3.8E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/63743|m.16786 | UnnamedSample_HQ_transcript/63743 | Coverage 0.923 too low. | 37315a9a7e6206c19a44c143bedf06cf | 555 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 75 | 535 | 3.9E-84 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/8309|m.3294 | UnnamedSample_HQ_transcript/8309 | Coverage 0.202 too low. | b89b76fbba4736056e4aa5e4593d4e95 | 411 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 102 | 343 | 1.0E-91 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/44416|m.12799 | UnnamedSample_HQ_transcript/44416 | Coverage 0.362 too low. | b89b76fbba4736056e4aa5e4593d4e95 | 411 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 102 | 343 | 1.0E-91 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/41853|m.12228 | UnnamedSample_HQ_transcript/41853 | Coverage 0.943 too low. | 63b55e34e11e4298480e75ae01e143c3 | 771 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 355 | 405 | 8.9E-13 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/3412|m.1595 | UnnamedSample_HQ_transcript/3412 | Identity 0.905 too low. | 79d3578e7267b875520efd734f56b650 | 1504 | Pfam | PF00053 | Laminin EGF domain | 709 | 758 | 7.7E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3412|m.1595 | UnnamedSample_HQ_transcript/3412 | Identity 0.905 too low. | 79d3578e7267b875520efd734f56b650 | 1504 | Pfam | PF00053 | Laminin EGF domain | 133 | 190 | 1.9E-11 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3412|m.1595 | UnnamedSample_HQ_transcript/3412 | Identity 0.905 too low. | 79d3578e7267b875520efd734f56b650 | 1504 | Pfam | PF00053 | Laminin EGF domain | 761 | 809 | 3.4E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3412|m.1595 | UnnamedSample_HQ_transcript/3412 | Identity 0.905 too low. | 79d3578e7267b875520efd734f56b650 | 1504 | Pfam | PF00053 | Laminin EGF domain | 554 | 602 | 1.2E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3412|m.1595 | UnnamedSample_HQ_transcript/3412 | Identity 0.905 too low. | 79d3578e7267b875520efd734f56b650 | 1504 | Pfam | PF00053 | Laminin EGF domain | 812 | 854 | 5.3E-11 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3412|m.1595 | UnnamedSample_HQ_transcript/3412 | Identity 0.905 too low. | 79d3578e7267b875520efd734f56b650 | 1504 | Pfam | PF00053 | Laminin EGF domain | 70 | 125 | 4.9E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3412|m.1595 | UnnamedSample_HQ_transcript/3412 | Identity 0.905 too low. | 79d3578e7267b875520efd734f56b650 | 1504 | Pfam | PF00053 | Laminin EGF domain | 7 | 57 | 2.7E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3412|m.1595 | UnnamedSample_HQ_transcript/3412 | Identity 0.905 too low. | 79d3578e7267b875520efd734f56b650 | 1504 | Pfam | PF00053 | Laminin EGF domain | 506 | 551 | 3.5E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3412|m.1595 | UnnamedSample_HQ_transcript/3412 | Identity 0.905 too low. | 79d3578e7267b875520efd734f56b650 | 1504 | Pfam | PF00053 | Laminin EGF domain | 650 | 706 | 2.6E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3412|m.1595 | UnnamedSample_HQ_transcript/3412 | Identity 0.905 too low. | 79d3578e7267b875520efd734f56b650 | 1504 | Pfam | PF00053 | Laminin EGF domain | 860 | 902 | 1.4E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3412|m.1595 | UnnamedSample_HQ_transcript/3412 | Identity 0.905 too low. | 79d3578e7267b875520efd734f56b650 | 1504 | Pfam | PF00053 | Laminin EGF domain | 244 | 282 | 1.2E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/3412|m.1595 | UnnamedSample_HQ_transcript/3412 | Identity 0.905 too low. | 79d3578e7267b875520efd734f56b650 | 1504 | Pfam | PF00053 | Laminin EGF domain | 193 | 241 | 3.6E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/27599|m.8860 | UnnamedSample_HQ_transcript/27599 | Coverage 0.069 too low. | 1afcf7f81fb92dced41030919b1808f9 | 508 | Pfam | PF01595 | Cyclin M transmembrane N-terminal domain | 267 | 437 | 2.0E-36 | T | 22-09-2020 | IPR002550 | CNNM, transmembrane domain |
| UnnamedSample_HQ_transcript/52079|m.14474 | UnnamedSample_HQ_transcript/52079 | Coverage 0.913 too low. | 367cf4dbe2ba8e731f71d0e8590274df | 644 | Pfam | PF14826 | FACT complex subunit SPT16 N-terminal lobe domain | 6 | 169 | 5.0E-46 | T | 22-09-2020 | IPR029148 | FACT complex subunit Spt16, N-terminal lobe domain |
| UnnamedSample_HQ_transcript/52079|m.14474 | UnnamedSample_HQ_transcript/52079 | Coverage 0.913 too low. | 367cf4dbe2ba8e731f71d0e8590274df | 644 | Pfam | PF08644 | FACT complex subunit (SPT16/CDC68) | 536 | 644 | 1.7E-34 | T | 22-09-2020 | IPR013953 | FACT complex subunit Spt16 domain |
| UnnamedSample_HQ_transcript/52079|m.14474 | UnnamedSample_HQ_transcript/52079 | Coverage 0.913 too low. | 367cf4dbe2ba8e731f71d0e8590274df | 644 | Pfam | PF00557 | Metallopeptidase family M24 | 184 | 414 | 8.7E-24 | T | 22-09-2020 | IPR000994 | Peptidase M24 |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
